586 posters, 8 topics, 23 sessions, 1,077 authors, 622 institutions

ISQua's 40th International Conference 2024

24th - 27th September 2024 | Istanbul, Türkiye

ISQUA2024-ABS-1307

The ADR journey – improving adverse drug reaction management to decrease risk of patient harm

View Poster Contact Presenter

Poster Presenter

Linda GRAUDINS

Authors

Linda Graudins, Ar Kar Aung, Celia Zubrinich

Affiliations

ALFRED HEALTH, Alfred Health, Melbourne, Australia, Department of General Medicine, Alfred Health, Victoria, Australia, Allergy and Asthma Unit, AlfredHealth,Victoria, Australia

Part of Topic

Patient Safety & Quality Improvement

The Adverse Drug Reaction Journey: Improving Management to Decrease Patient Harm

Alfred Health: 800–bed inpatient referral network of hospitals in Melbourne providing state–wide health services to Victoria, Australia.

Adverse Drug Reaction (ADR)s are reviewed by a multidisciplinary committee with specialists in allergy, dermatology, general medicine, infectious diseases, medicines information, medication safety.

In 2023 there were 231 referrals reviewed

•8% severe cutaneous adverse reactions (SCARS*)

•20% medication-related anaphylaxis

•antimicrobial agents moist commonly implicated (48%)

•38% inpatients had at least one ADR documented on admission

My Health Record (MHR); national electronic patient held health information system.Registered healthcare providers and patients may access medications prescribed, dispensed, hospital discharge summaries, pathology, medical imaging, adverse reactions/allergies.

Patient harm from ADRs occurs with incomplete communication and allergy documentation, lack of patient and clinician knowledge.

Aim

Decrease the risk of patient harm by improving:

ØClinician competency in identifying and managing ADRs

ØDocumentation and communication of severe adverse reactions for patients and clinicians